Skip to Main Content

Paper Details

Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers.
Cancer Res
2
2023
AR, AR cells, Abemaciclib, CDK4, CDK4/6i, CDK4/6is, Cyclin-dependent kinases 4/6, ET, HER2, HER2-, HR, Hormone Receptor-Positive Metastatic Breast Cancers, MBC, PDX, PDX-derived organoids, PDxO, PR, PR and AR breast cancer cells, PR breast cancer, PR cells, Palbociclib, abemaciclib, breast cancer, breast cancers, cyclin-dependent kinases 4/6, hormone receptor, metastatic breast cancer, organoid models, palbociclib, patient, patients
Author NameAffiliation
Funda Meric-BernstamThe University of Texas MD Anderson Cancer Center
Kelly K HuntThe University of Texas MD Anderson Cancer Center
Kelly K HuntThe University of Texas MD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2